huafei Zou - Publications

Affiliations: 
2012-2014 California Institute for Biomedical Research 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Tian Y, Zou H, An P, Zhou Z, Shen W, Lin Q. Design of Stapled Oxyntomodulin Analogs Containing Functionalized Biphenyl Cross-Linkers. Tetrahedron. 75: 286-295. PMID 30581241 DOI: 10.1016/j.tet.2018.11.060  0.6
2018 Muppidi A, Lee SJ, Hsu CH, Zou H, Lee C, Pflimlin E, Mahankali M, Yang P, Chao E, Ahmad I, Crameri A, Wang D, Woods A, Shen W. Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs. Bioconjugate Chemistry. PMID 30543420 DOI: 10.1021/acs.bioconjchem.8b00764  0.6
2018 Yang P, Zou H, Lee C, Muppidi A, Chao E, Fu Q, Luo X, Wang D, Schultz PG, Shen W. A Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate-Induced Mouse Colitis Models. Journal of Medicinal Chemistry. PMID 29528634 DOI: 10.1021/acs.jmedchem.7b00768  0.6
2017 Lee SJ, Mahankali M, Bitar A, Zou H, Chao E, Nguyen H, Gonzalez J, Caballero D, Hull M, Wang D, Schultz PG, Shen W. A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening. Scientific Reports. 7: 5824. PMID 28724938 DOI: 10.1038/s41598-017-05163-w  0.6
2016 Liu Y, Wang Y, Zhang Y, Liu T, Jia H, Zou H, Fu Q, Zhang Y, Lu L, Chao E, Parker H, Nguyen-Tran V, Shen W, Wang D, Schultz PG, et al. Rational Design of Dual Agonist-Antibody Fusions as Long-acting Therapeutic Hormones. Acs Chemical Biology. PMID 27704775 DOI: 10.1021/acschembio.6b00630  0.6
2016 Wang Y, Du J, Zou H, Liu Y, Zhang Y, Gonzalez J, Chao E, Lu L, Yang P, Parker H, Nguyen-Tran V, Shen W, Wang D, Schultz PG, Wang F. Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide Receptors. Angewandte Chemie (International Ed. in English). PMID 27595986 DOI: 10.1002/anie.201606321  0.6
2016 Yang PY, Zou H, Chao E, Sherwood L, Nunez V, Keeney M, Ghartey-Tagoe E, Ding Z, Quirino H, Luo X, Welzel G, Chen G, Singh P, Woods AK, Schultz PG, et al. Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery. Proceedings of the National Academy of Sciences of the United States of America. 113: 4140-5. PMID 27035989 DOI: 10.1073/pnas.1601653113  0.6
2016 Muppidi A, Zou H, Yang PY, Chao E, Sherwood L, Nunez V, Woods AK, Schultz PG, Lin Q, Shen W. Design of Potent and Proteolytically Stable Oxyntomodulin Analogs. Acs Chemical Biology. 11: 324-8. PMID 26727558 DOI: 10.1021/acschembio.5b00787  0.6
2015 Cheng X, Shen W, Zou H, Shen L, Gu X, Huang D, Sun Y, Wang B, Tian Q, Xu J. [Analysis of CSF1R gene mutation in a Chinese family with hereditary diffuse leukoencephalopathy with neuroaxonal spheroids]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics. 32: 208-12. PMID 25863088 DOI: 10.3760/cma.j.issn.1003-9406.2015.02.012  0.6
2015 Zhang Y, Zou H, Wang Y, Caballero D, Gonzalez J, Chao E, Welzel G, Shen W, Wang D, Schultz PG, Wang F. Rational design of a humanized glucagon-like peptide-1 receptor agonist antibody. Angewandte Chemie (International Ed. in English). 54: 2126-30. PMID 25556336 DOI: 10.1002/anie.201410049  0.6
Show low-probability matches.